Parallax Volatility Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,134
Closed -$588K 1591
2026
Q1
$588K Sell
8,134
-6,651
-45% -$524K ﹤0.01% 1033
2025
Q4
$1.21M Buy
14,785
+12,255
+484% +$955K ﹤0.01% 1062
2025
Q3
$190K Buy
+2,530
New +$189K ﹤0.01% 1373
2025
Q2
Sell
-3
Closed -$209 1654
2025
Q1
$242 Buy
+3
New +$258 ﹤0.01% 1484
2024
Q4
Sell
-14,397
Closed -$1.35M 2137
2024
Q3
$1.35M Buy
14,397
+900
+7% +$75.5K ﹤0.01% 1264
2024
Q2
$1.05M Buy
13,497
+7,187
+114% +$586K ﹤0.01% 1246
2024
Q1
$574K Buy
6,310
+259
+4% +$21.6K ﹤0.01% 1373
2023
Q4
$468K Sell
6,051
-78,943
-93% -$5.53M ﹤0.01% 1613
2023
Q3
$5.78M Buy
84,994
+38,200
+82% +$2.78M 0.01% 713
2023
Q2
$3.8M Buy
46,794
+20,846
+80% +$1.66M 0.01% 898
2023
Q1
$2.13M Buy
+25,948
New +$1.85M ﹤0.01% 1211

Other funds holding GEHC

Parallax Volatility Advisers's GEHC Position: Q2 2026 in Review

Parallax Volatility Advisers sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 8,134 shares — an estimated $588K sold.

Parallax Volatility Advisers first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $5.78M in Q3 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Parallax Volatility Advisers reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,134 GE HealthCare shares in Q2 2026, an estimated $588K.
  • Parallax Volatility Advisers first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Parallax Volatility Advisers's GE HealthCare position peaked at $5.78M in Q3 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.